ArticleCancer cell international2024
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation.
Kristina Vukovic Derfi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it